, Volume 174, Issue 2, pp 121–130 | Cite as

Susceptibilities to Amphotericin B, Fluconazole and Voriconazole of Trichosporon Clinical Isolates

  • Moan Shane Tsai
  • Yun Liang Yang
  • An Huei Wang
  • Lih Shinn Wang
  • Daniel C. T. Lu
  • Ci Hong Liou
  • Li Yun Hsieh
  • Chi Jung Wu
  • Ming Fang Cheng
  • Zhi Yuan Shi
  • Hsiu Jung Lo


A total of 35 Trichosporon isolates were collected from the Taiwan Surveillance of Antimicrobial Resistance of Yeasts (TSARY) project from 1999 to 2006, and their identifications as well as drug susceptibilities were determined. The most frequently isolated species was T. asahii (62.9%), and the most common clinical sample that yielded Trichosporon isolates was urine (37.1%). The etiology of all seven invasive trichosporonosis was T. asahii. For the 22 T. asahii isolates, the MIC50 and MIC90 for amphotericin B were 0.25 and 1 μg/mL, respectively. Those for fluconazole were 2 and 4 μg/mL, respectively, and for voriconazole 0.031 and 0.063 μg/mL, respectively. When the intraclass correlation coefficients (ICCs) and agreements were calculated, we found that the MICs of fluconazole obtained from different methods were similar and the inter-method discrepancies were low. Nevertheless, no unanimous MIC of amphotericin B and voriconazole was obtained among different methods.


Antifungal susceptibility testing CLSI EUCAST Trichosporon 



The authors would like to thank Bristol Myers Squibb for supplying the reference powder of amphotericin B, and Pfizer for fluconazole and voriconazole. They also thank the TSARY hospitals, especially the following 17, for providing clinical Trichosporon isolates: Chang Gung Memorial Hospital at Keelung, Chang Gung Memorial Hospital at Linkou, Chi-Mei Foundation Hospital, Chung Shan Medical Dental College Hospital, Tainan Municipal Hospital, Kuan-Tien General Hospital, Lo-Hsu Foundation Inc. Lo-Tung Poh Ai Hospital, Kaohsiung Military Hospital, Hua-Lien Mennonite Church Hospital, National Cheng-Kung University Hospital, Hua-Lien Hospital, DOH, the Executive Yuan, Show Chwan Memorial Hospital, Tri Service General Hospital, Veterans General Hospital—Taichung, Veterans General Hospital-Kaohsiung, Asia East Memorial Hospital, and Buddhist Tzu-Chi General Hospital. This work was supported in part by the NHRI fellowship research grant to MST and by grants CL-098-PP-04 and ID-099-PP-04 from the NHRI to HJL.

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.


  1. 1.
    Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36:187–91.PubMedGoogle Scholar
  2. 2.
    Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, et al. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol. 2010;48:328–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol. 2004;25:60–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Yang YL, Li SY, Cheng HH, Lo HJ. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis. 2005;51:179–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, et al. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn Microbiol Infect Dis. 2008;61:175–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev. 2011;24:682–700.PubMedCrossRefGoogle Scholar
  7. 7.
    Ellner K, McBride ME, Rosen T, Berman D. Prevalence of Trichosporon beigelii. Colonization of normal perigenital skin. J Med Vet Mycol. 1991;29:99–103.PubMedCrossRefGoogle Scholar
  8. 8.
    Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol. 2009;47:1074–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Hajjeh RA, Blumberg HM. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis. 1995;20:913–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Tashiro T, Nagai H, Kamberi P, Goto Y, Kikuchi H, Nasu M, et al. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur J Clin Microbiol Infect Dis. 1994;13:218–24.PubMedCrossRefGoogle Scholar
  11. 11.
    Walsh TJ. Trichosporonosis. Infect Dis Clin North Am. 1989;3:43–52.PubMedGoogle Scholar
  12. 12.
    Guo LN, Xiao M, Kong F, Chen SC, Wang H, Sorrell TC, et al. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol. 2011;49:3805–11.PubMedCrossRefGoogle Scholar
  13. 13.
    Li HM, Du HT, Liu W, Wan Z, Li RY. Microbiological characteristics of medically important Trichosporon species. Mycopathologia. 2005;160:217–25.PubMedCrossRefGoogle Scholar
  14. 14.
    Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother. 2005;49:4026–34.PubMedCrossRefGoogle Scholar
  15. 15.
    Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis. 2009;49:e11–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Clinical Laboratory Standards Institute CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition. CLSI document M27-A3. Wayne, PA; 2008.Google Scholar
  17. 17.
    Testing SoASTotEECfAS. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing: EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect. 2008;14:982–4.CrossRefGoogle Scholar
  18. 18.
    McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46.CrossRefGoogle Scholar
  19. 19.
    Lo HJ, Ho AH, Ho M. Factors accounting for mis-identification of Candida species. J Microbiol Immunol Infect. 2001;34:171–7.PubMedGoogle Scholar
  20. 20.
    Leaw SN, Chang HC, Barton R, Bouchara JP, Chang TC. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J Clin Microbiol. 2007;45:2220–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol. 2006;44:693–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol. 2010;48:141–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Nakajima M, Sugita T, Mikami Y. Granuloma associated with Trichosporon asahii infection in the lung: Unusual pathological findings and PCR detection of Trichosporon DNA. Med Mycol. 2007;45:641–4.PubMedCrossRefGoogle Scholar
  24. 24.
    Taj-Aldeen SJ, Al-Ansari N, El Shafei S, Meis JF, Curfs-Breuker I, Theelen B, et al. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol. 2009;47:1791–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43:1818–28.PubMedCrossRefGoogle Scholar
  26. 26.
    Suzuki K, Nakase K, Kyo T, Kohara T, Sugawara Y, Shibazaki T, et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol. 2010;84:441–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Bayramoglu G, Sonmez M, Tosun I, Aydin K, Aydin F. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection. 2008;36:68–70.PubMedCrossRefGoogle Scholar
  28. 28.
    Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol. 2008;25:221–5.PubMedCrossRefGoogle Scholar
  29. 29.
    McGinnis MR, Pasarell L, Sutton DA, Fothergill AW, Cooper CR Jr, Rinaldi MG. In vitro activity of voriconazole against selected fungi. Med Mycol. 1998;36:239–42.PubMedGoogle Scholar
  30. 30.
    Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother. 2002;46:1144–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Perparim K, Nagai H, Hashimoto A, Goto Y, Tashiro T, Nasu M. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J Chemother. 1996;8:445–8.PubMedGoogle Scholar
  32. 32.
    Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis. 2000;38:101–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Thompson GR III, Wiederhold NP, Sutton DA, Fothergill A, Patterson TF. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species. J Antimicrob Chemother. 2009;64:79–83.PubMedCrossRefGoogle Scholar
  34. 34.
    Febre N, Silva V, Medeiros EA, Wey SB, Colombo AL, Fischman O. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol. 1999;37:1584–6.PubMedGoogle Scholar
  35. 35.
    Mori Y, Hiraoka M, Katsu M, Tsukahara H, Mikami Y, Mayumi M. Marked renal damage in a child with hydronephrosis infected by Trichosporon asahii. Pediatr Nephrol. 2005;20:234–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Wolf DG, Falk R, Hacham M, Theelen B, Boekhout T, Scorzetti G, et al. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol. 2001;39:4420–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Moan Shane Tsai
    • 1
  • Yun Liang Yang
    • 2
    • 3
  • An Huei Wang
    • 1
  • Lih Shinn Wang
    • 4
  • Daniel C. T. Lu
    • 5
  • Ci Hong Liou
    • 1
  • Li Yun Hsieh
    • 1
  • Chi Jung Wu
    • 1
    • 6
  • Ming Fang Cheng
    • 7
    • 8
  • Zhi Yuan Shi
    • 9
  • Hsiu Jung Lo
    • 1
    • 10
  1. 1.National Institute of Infectious Diseases and VaccinologyNational Health Research InstitutesZhunan Town, Miaoli CountyTaiwan
  2. 2.Department of Biological Science and TechnologyNational Chiao Tung UniversityHsinchuTaiwan
  3. 3.Institute of Molecular Medicine and BioengineeringNational Chiao Tung UniversityHsinchuTaiwan
  4. 4.Division of Infectious DiseasesBuddhist Tzu-Chi General HospitalHulienTaiwan
  5. 5.Division of Infectious DiseasesLo-Hsu Foundation Inc., Lo-Tung Poh Ai HospitalYilanTaiwan
  6. 6.Division of Infectious DiseasesNational Cheng-Kung University Hospital and Medical CollegeTainanTaiwan
  7. 7.Division of Infectious DiseasesVeterans General Hospital—KaohsiungKaohsiungTaiwan
  8. 8.National Yang-Ming UniversityTaipeiTaiwan
  9. 9.Division of Infectious DiseasesVeterans General Hospital—TaichungTaichungTaiwan
  10. 10.School of DentistryChina Medical UniversityTaichungTaiwan

Personalised recommendations